Reading LIN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track LIN free→Reading LIN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track LIN free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on steady earnings growth. The current thesis state is intact, supported by strong recent financial performance but tempered by management volatility and sector challenges.
The market currently prices LIN at an expensive valuation compared to its peers, reflecting a premium of 1.24 times. There is an expectations gap of 0.39, indicating that investors may be anticipating continued strong performance despite recent mixed execution quality.
Management is on track to increase earnings per share (EPS) by 7% to 9% for 2026 and achieve Q2 EPS growth of 8% to 10%. However, there is a moderate risk of missing estimates, as LIN has struggled with execution in recent quarters.
The long-term thesis hinges on LIN's ability to maintain its earnings growth targets and the performance of sector bellwethers like SHW, ECL, and APD. If these companies continue to perform well, it could support LIN's momentum; conversely, any negative guidance from them could pose risks.
Overall, LIN's fundamentals show promise, but the expensive valuation and sector headwinds warrant caution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.